COVID-19: Perspectives on the Regional Impact in Brazil — Edition 3 Presentations June 30, 2020 Maurício França Rafael Freixo
Related Practice Healthcare Services Much is still unknown or uncertain about COVID-19. In particular, data accuracy in Brazil is low due to the limited number of tests and the unavailability of granular public data. 01262022160122
Executive Insights Healthcare Services Global-Local Governance in Pharma Launches: Enabler of Success or Hidden Bottleneck? October 3, 2025
Executive Insights Healthcare Services Indonesian Private Healthcare: Investing in a “Dual-Speed” Services Market August 26, 2025
Executive Insights Life Sciences & Pharma Unlocking Brazil’s Clinical Trial Opportunity: A Strategic Roadmap for Healthcare Leaders August 18, 2025
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (China) July 22, 2025
Executive Insights Healthcare Services Surge in US C-SNPs: A Bright Spot in a Challenged Medicare Advantage Market May 22, 2025